Capital Flow Monitor · Sponsors · CIK 1778475
Strand Therapeutics Inc.
20 Overland Street, Boston, MA, 02215 · 617-993-9271
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$120.1M
Sold
$108.1M
% sold
90.0%
Investors
10
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-17 | D ·current | 506(b) | $120.1M | $108.1M | 90.0% | 10 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Jacob Becraft — Executive Officer / Director / Promoter, Boston, MA
- Tasuku Kitada — Executive Officer / Director / Promoter, Boston, MA
- Ala Alenazi — Director, Boston, MA
-
Pegah Ebrahimi — Director, Boston, MA
3 other raises
- Piston Technologies, Inc. $15.0M of $15.0M · 100.0%
- FPV Strand SPV, L.P. $3.0M of —
- Astra Inc. $10.0M of $15.0M · 66.7%
-
Jory Bell — Director, Boston, MA
3 other raises
- Playground Ventures IV, L.P. $475.0M of $475.0M · 100.0%
- Playground Omega, L.P. $3.7M of $3.7M · 100.0%
- Playground Omega 2, L.P. $2.2M of $2.2M · 100.0%
- Jeb Keiper — Director, Boston, MA
- Samta Kundu — Executive Officer, Boston, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.